CAPA Letter on Draft Canadian Drug Pricing Guidelines

CAPA Letter on Draft Canadian Drug Pricing Guidelines

Access to the right medicines is an important component in managing arthritis. In Canada, the Patented Medicines Prices Review Board (PMPRB) plays a key role in drug pricing in Canada. On July 1, 2020, the newly amended Patented Medicines Regulations will come into...
Safety of Medications and Substances During Pregnancy

Safety of Medications and Substances During Pregnancy

In April 2019, The Hospital for Sick Children (SickKids) in Toronto shut down its Motherisk program. The Motherisk program, initially established in 1985, provided information on the safety of medications and substances during pregnancy. In May, the Society of...
Backgrounder for Bill C-17

Backgrounder for Bill C-17

Bill C-17 amends the Food and Drugs Act, which hasn’t been substantially updated in over 50 years. It was introduced to the House of Commons by the Minister of Health in December 2013. The Bill has two main goals: Strengthen safety oversight of therapeutic products...